Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestMortgage LoansNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - DoubtfulReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Finished Goods (2023 - 2025)

WORK Medical Technology filings provide 3 years of Finished Goods readings, the most recent being $1.4 million for Q3 2025.

  • On a quarterly basis, Finished Goods rose 2.81% to $1.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.4 million, a 2.81% increase, with the full-year FY2025 number at $1.4 million, up 2.81% from a year prior.
  • Finished Goods hit $1.4 million in Q3 2025 for WORK Medical Technology, up from $1.4 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $2.1 million in Q3 2023 to a low of $1.4 million in Q3 2024.
  • Median Finished Goods over the past 3 years was $1.4 million (2025), compared with a mean of $1.6 million.
  • Biggest five-year swings in Finished Goods: plummeted 34.59% in 2024 and later rose 2.81% in 2025.
  • WORK Medical Technology's Finished Goods stood at $2.1 million in 2023, then plummeted by 34.59% to $1.4 million in 2024, then rose by 2.81% to $1.4 million in 2025.
  • The last three reported values for Finished Goods were $1.4 million (Q3 2025), $1.4 million (Q3 2024), and $2.1 million (Q3 2023) per Business Quant data.